×

Detection of chromosome structural variation by targeted next-generation sequencing and a deep learning application

Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.

Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.

Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis.

Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing.

Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS.
Next-Generation Sequencing Using S1 Nuclease for Poor-Quality Formalin-Fixed, Paraffin-Embedded Tumor Specimens.

Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping.

Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.

HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF.

Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene ASCL1 in pulmonary neuroendocrine tumors.

KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.

Lynch syndrome-related small intestinal adenocarcinomas.

Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer.

Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma.

Genomic alterations of anaplastic thyroid carcinoma detected by targeted massive parallel sequencing in a BRAFV600E mutation-prevalent area.

Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer.

Reappraisal of hMLH1 promoter methylation and protein expression status in the serrated neoplasia pathway.

The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.

Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict
Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer

Comprehensive genomic profiles of small cell lung cancer.

Epigenetic modulation with HDAC inhibitor CG200745 induces anti-proliferation in non-small cell lung cancer cells.

Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival.

Sessile serrated adenoma/polyps with a depressed surface: a rare form of sessile serrated adenoma/polyp.

Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.

Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor.

Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.

Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma.

Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.

Protuberant fibro-osseous lesions of the temporal bone: two additional case reports.